How to Value a Dental Group Practice (Multi-Location) in 2026

Multi-location dental groups are the most actively pursued acquisition targets in healthcare M&A right now. Aspen Dental, Heartland Dental, Pacific Dental Services, MB2 Dental, and dozens of PE-backed DSOs are competing for groups with 3+ locations. I've been on both sides of these transactions — advising the dental group owners selling to DSOs and advising the PE firms building dental platforms — and the valuation dynamics for multi-location groups are fundamentally different from single-practice dental valuations.

The core insight is what I call the "platform premium." Three individual dental practices doing $500K EBITDA each might sell for $2.5M-$3.5M apiece (5-7x). Combine them under unified management with shared back-office and a regional brand, and the group might sell for $12M-$15M (8-10x of the combined $1.5M EBITDA). Same clinics, same patients, same revenue — 30-50% more enterprise value. Understanding why this premium exists and how to capture it is what this guide is about.

What Multi-Location Dental Groups Sell For

EBITDA multiples for dental groups depend on size, growth profile, and management infrastructure. Here's what I'm seeing in 2026:

• 3-5 locations, $1M-$2M EBITDA: 7.0-10.0x EBITDA. This is the entry point for DSO interest. Groups at this size have typically built some management infrastructure (an operations manager, centralized scheduling) but the founding dentist is still heavily involved clinically and managerially.
• 6-12 locations, $2M-$5M EBITDA:9.0-12.0x EBITDA. At this scale, you've proven the model is repeatable. You have regional managers, standardized clinical protocols, and a brand that patients recognize. PE-backed DSOs will compete aggressively for these groups.
• 13-25 locations, $5M-$15M EBITDA: 11.0-14.0x EBITDA. These are platform-grade acquisitions. A PE firm can build an entire dental investment thesis around a group this size, using it as the foundation for a 50-100 location platform through add-on acquisitions.
• 25+ locations, $15M+ EBITDA:12.0-16.0x EBITDA. At this scale, you're attracting large-cap PE firms and potentially strategic DSO acquirers. The multiple reflects the management depth, geographic coverage, and proven scalability.

Compare these multiples to individual practices at 5-7x EBITDA and the platform premium becomes obvious. A 3-location group doesn't just get 3x the value of one practice — it gets a higher multiple on the aggregated earnings.

Why the Platform Premium Exists

DSOs and PE firms pay platform premiums for multi-location groups because these groups solve the three hardest problems in dental roll-up strategy:

Management infrastructure.The single biggest bottleneck in dental consolidation isn't finding practices to buy — it's managing them post-acquisition. A group with 8 locations already has an operations playbook, HR systems, training programs, and a management team that can absorb new locations. That infrastructure might cost a DSO $2M-$4M and 18-24 months to build from scratch. Buying it is faster and lower risk.

Associate recruitment and retention. Dental groups with multiple locations can offer associates career paths — clinical mentorship, potential partnership tracks, location transfers, and specialty development. A solo practice can offer a job. In a market where associate recruitment costs $15K-$30K per hire and annual associate turnover at DSOs runs 25-35%, a group with strong associate retention is solving a multi-million dollar problem.

Organic growth optionality. Groups that have successfully opened de novo locations demonstrate a repeatable expansion capability. A de novo dental office costs $400K-$700K to build out and takes 18-24 months to reach profitability, but at maturity generates $200K-$400K EBITDA. Buyers value this optionality because it represents growth without paying acquisition multiples.

De Novo vs. Acquired Locations: Buyers Care About the Mix

Not all locations in your group are valued equally. Buyers categorize your locations and apply different scrutiny to each:

Acquired and integrated locationsare valued at the group-level multiple if they're performing at or above the group's average metrics (collections per location, EBITDA margin, patient retention). If they're underperforming, buyers will model improvement plans but discount the expected gains.

De novo locations that have reached maturity (2+ years old, positive EBITDA, 1,200+ active patients) are the most valuable because they demonstrate your ability to build from scratch. Each mature de novo is proof of concept for future expansion.

De novo locations still in ramp-up(under 18 months, not yet profitable) are valued differently. Buyers will credit some future value but apply a discount for the capital still needed to reach profitability. A group with three locations in ramp-up might see $300K-$500K in EBITDA add-back for these locations (their expected contribution at maturity minus current losses), but the buyer won't apply the full group multiple to that number.

The ideal profile that commands the highest multiple: 60-70% of locations are acquired and fully integrated, 20-30% are mature de novos, and 0-10% are in ramp-up. This mix shows both acquisition and organic growth capability.

Same-Store Growth: The Metric DSOs Obsess Over

Same-store revenue growth — the growth rate of locations that have been open for at least 12 months — is the single most important operating metric in a dental group valuation. It tells buyers whether your existing locations are gaining or losing momentum independent of new location openings.

Benchmark same-store growth rates:

• Below 0%: Declining same-store revenue is a serious red flag. Buyers will question patient retention, associate stability, and market dynamics.
• 0-3%: Stable but not exciting. Matches general dental market growth. No premium or penalty.
• 3-6%: Above-market growth. Indicates effective marketing, strong referral networks, or service line expansion. Adds 0.5-1.0x to your multiple.
• 6%+: Exceptional. Usually driven by adding specialty services (implants, orthodontics, pediatrics) to general practice locations. Can add 1.0-2.0x to multiple.

DSOs like Heartland and Pacific Dental have internal benchmarks of 4-6% same-store growth. If your group is achieving this organically, you're demonstrating that your operating model works — and that's exactly what a platform buyer is paying for.

Associate Retention: The Deal-Maker or Deal-Breaker

In every multi-location dental group transaction I've worked on, associate dentist retention is in the top three due diligence items. Here's why it matters so much.

A dental group with 10 locations and 15 associate dentists depends on those associates for 70-80% of production. If 4 associates leave in the 12 months following an acquisition (a common scenario when ownership changes), the group loses 25% of its clinical workforce. Recruiting replacements takes 3-6 months per position. During that gap, 2-3 locations are operating at reduced capacity, collections drop, and the acquisition thesis falls apart.

Buyers mitigate this risk by examining:

• Associate tenure: Average tenure above 3 years is strong. Below 2 years suggests a revolving door that will likely continue post-sale.
• Compensation structure: Associates on percentage-of-production (typically 25-35% of collections) with guaranteed minimums are the industry standard. Groups that offer additional incentives — CE budgets, partnership tracks, sign-on bonuses with 2-year claw-backs — retain better.
• Employment agreements: Written agreements with non-compete clauses (enforceable in most states for dental) and 90-day notice periods protect the buyer. A group where associates work on handshake agreements is a risk that buyers will price into the deal.
• Post-transaction retention plan: Sophisticated sellers develop associate retention packages before going to market. Stay bonuses of $25K-$75K per associate, vesting over 2-3 years, are common and often funded by the buyer as part of deal economics.

EBITDA Adjustments Specific to Dental Groups

Dental group EBITDA calculations involve several adjustments that don't apply to single practices. Buyers and their quality of earnings teams will reconstruct your EBITDA with these in mind:

• Owner compensation normalization: If the founding dentist earns $600K across clinical production and management, the buyer will replace the management salary with a market-rate operations manager ($120K-$180K) and the clinical production with an associate dentist (25-30% of that production). The difference between your total comp and the replacement cost is added back to EBITDA.
• Corporate overhead allocation: Groups with a central office (billing, HR, marketing) have overhead that may include personal expenses, above-market rent on owner-held real estate, or family member compensation. All of this gets normalized.
• Lab costs: Groups that use in-house labs may have different cost structures than groups outsourcing to commercial labs. Buyers normalize to market lab rates.
• Real estate: If you own the real estate and lease it to the practice at above-market rates, the buyer will adjust to market rent. Conversely, below-market leases add value to the practice entity.

The DSO Landscape: Who's Buying and What They Pay

The DSO buyer universe in 2026 is deep. Here's a quick map of the major buyer categories and their typical approach:

• Large national DSOs (Aspen Dental, Heartland, Pacific Dental): Focused on bolt-on acquisitions in existing markets. Pay 6-9x EBITDA for add-ons. Less interested in platform acquisitions because they already have infrastructure.
• PE-backed emerging DSOs (MB2 Dental, Dental Care Alliance, etc.): Actively building platforms. Will pay 9-14x EBITDA for groups that can serve as regional platforms. These are your premium buyers.
• New PE platform searches:PE firms looking to enter dental for the first time. They'll pay the highest multiples (12-16x) for the right platform because they need management, systems, and market presence all at once. Getting into a PE fund's dental thesis at the platform stage is how you capture the maximum premium.

Preparing Your Group for Maximum Value

If you're 12-24 months from a potential sale, here's what moves the needle:

• Lock up your associates with written employment agreements and non-competes
• Standardize clinical protocols and operating procedures across all locations
• Implement a single practice management system across the group (Dentrix Enterprise, Open Dental, or similar)
• Build an operations manager role that can run day-to-day without you
• Demonstrate same-store growth with clean, location-level financial reporting
• Secure long-term leases (7+ years remaining) at all locations
• Get a quality of earnings report done before going to market — surprises in due diligence kill deals and destroy trust

The Bottom Line

Multi-location dental groups trade at 7-14x EBITDA — a substantial premium over individual practices — because they offer what DSOs and PE firms value most: management infrastructure, growth optionality, and a proven operating model. The platform premium is real, but capturing it requires demonstrating that your group is more than a collection of individual practices. Associate retention, same-store growth, standardized operations, and a management team that transcends the founding dentist are what separate a $10M exit from a $20M exit. Start building those assets years before you plan to sell, and you'll have DSOs competing for your group rather than dictating terms.